Literature DB >> 25959068

The roles of extracellular related-kinases 1 and 2 signaling in CNS myelination.

David Gonsalvez1, Anita H Ferner1, Haley Peckham1, Simon S Murray2, Junhua Xiao3.   

Abstract

Substantial progress has been made in identifying the intracellular signaling pathways that regulate central nervous system myelination. Recently, the mitogen activated protein kinase pathway, in particular the extracellular signal-related kinase 1 (Erk1) and Erk2, have been identified as critically important in mediating the effects of several growth factors that regulate oligodendroglial development and myelination. Here we will review the recent studies that identify the key role that Erk1/2 signaling plays in regulating oligodendroglial development, myelination and remyelination, discuss the potential mechanisms that Erk1/2 may utilize to influence myelination, and highlight some questions for further research. This article is part of the Special Issue entitled 'Oligodendrocytes in Health and Disease'.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Akt; BDNF; Erk; Fyn; Myelin; Oligodendrocyte

Mesh:

Substances:

Year:  2015        PMID: 25959068     DOI: 10.1016/j.neuropharm.2015.04.024

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  24 in total

1.  Increased expression of ApoA1 after neuronal injury may be beneficial for healing.

Authors:  Mohor B Sengupta; Suparna Saha; Pradeep K Mohanty; Kiran K Mukhopadhyay; Debashis Mukhopadhyay
Journal:  Mol Cell Biochem       Date:  2016-10-13       Impact factor: 3.396

2.  Independent and cooperative roles of the Mek/ERK1/2-MAPK and PI3K/Akt/mTOR pathways during developmental myelination and in adulthood.

Authors:  Akihiro Ishii; Miki Furusho; Wendy Macklin; Rashmi Bansal
Journal:  Glia       Date:  2019-02-13       Impact factor: 7.452

Review 3.  Severe Convulsions and Dysmyelination in Both Jimpy and Cx32/47 -/- Mice may Associate Astrocytic L-Channel Function with Myelination and Oligodendrocytic Connexins with Internodal Kv Channels.

Authors:  Y H Gerald Chaban; Ye Chen; Elna Hertz; Leif Hertz
Journal:  Neurochem Res       Date:  2017-02-18       Impact factor: 3.996

Review 4.  Intracellular signaling pathway regulation of myelination and remyelination in the CNS.

Authors:  Jenna M Gaesser; Sharyl L Fyffe-Maricich
Journal:  Exp Neurol       Date:  2016-03-05       Impact factor: 5.330

Review 5.  The impact of trophic and immunomodulatory factors on oligodendrocyte maturation: Potential treatments for encephalopathy of prematurity.

Authors:  Josine E G Vaes; Myrna J V Brandt; Nikki Wanders; Manon J N L Benders; Caroline G M de Theije; Pierre Gressens; Cora H Nijboer
Journal:  Glia       Date:  2020-11-30       Impact factor: 7.452

6.  Intrinsic and extrinsic regulators of oligodendrocyte progenitor proliferation and differentiation.

Authors:  Katrina L Adams; Kristin D Dahl; Vittorio Gallo; Wendy B Macklin
Journal:  Semin Cell Dev Biol       Date:  2020-10-22       Impact factor: 7.499

7.  Mek/ERK1/2-MAPK and PI3K/Akt/mTOR signaling plays both independent and cooperative roles in Schwann cell differentiation, myelination and dysmyelination.

Authors:  Akihiro Ishii; Miki Furusho; Rashmi Bansal
Journal:  Glia       Date:  2021-06-22       Impact factor: 7.452

8.  Intrauterine growth restriction followed by oxygen support uniquely interferes with genetic regulators of myelination.

Authors:  Jill Chang; Robert H Lurie; Abhineet Sharma; Mirrah Bashir; Camille M Fung; Robert W Dettman; Maria L V Dizon
Journal:  eNeuro       Date:  2021-06-07

9.  Gas6-Tyro3 signaling is required for Schwann cell myelination and possible remyelination.

Authors:  Tomohiro Torii; Junji Yamauchi
Journal:  Neural Regen Res       Date:  2016-02       Impact factor: 5.135

10.  Regulation of prefrontal cortex myelination by the microbiota.

Authors:  A E Hoban; R M Stilling; F J Ryan; F Shanahan; T G Dinan; M J Claesson; G Clarke; J F Cryan
Journal:  Transl Psychiatry       Date:  2016-04-05       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.